Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$1.66 - $2.31 $58,639 - $81,600
-35,325 Reduced 11.79%
264,223 $586,000
Q2 2023

Aug 21, 2023

BUY
$1.61 - $1.96 $154,690 - $188,318
96,081 Added 47.22%
299,548 $557,000
Q1 2023

May 09, 2023

SELL
$1.8 - $2.83 $6,962 - $10,946
-3,868 Reduced 1.87%
203,467 $394,000
Q4 2022

Feb 14, 2023

BUY
$2.05 - $5.5 $4,167 - $11,181
2,033 Added 0.99%
207,335 $510,000
Q3 2022

Nov 18, 2022

BUY
$0.94 - $5.99 $20,715 - $132,007
22,038 Added 12.03%
205,302 $1.02 Million
Q2 2022

Aug 15, 2022

BUY
$3.2 - $5.69 $586,444 - $1.04 Million
183,264 New
183,264 $860,000

Others Institutions Holding EQRX

About EQRx, Inc.


  • Ticker EQRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 448,140,992
  • Description
  • EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...
More about EQRX
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.